Literature DB >> 1909576

Structure-function relationships in human epidermal growth factor studied by site-directed mutagenesis and 1H NMR.

U Hommel1, T J Dudgeon, A Fallon, R M Edwards, I D Campbell.   

Abstract

In order to elucidate the mechanism of interaction between human epidermal growth factor (EGF) and its receptor, selected variants of EGF, differing by single amino acid substitutions, have been made by site-directed mutagenesis. The receptor affinity of these mutants was determined by a receptor binding competition assay, and the effects of the substitution on the structure of the protein were assessed by 1H nuclear magnetic resonance techniques. Various substitutions of Arg-41 resulted in substantial reduction in receptor affinity of EGF whereas change of Tyr-13 did not affect binding to the receptor. The 1H resonances of all nonexchangeable protons of the Tyr-13----Leu, Arg-41----His, and Leu-47----Glu variants were assigned and compared in order to assess the structural integrity of these mutants, which possess very different spectral and biological properties. In the case of the Leu-47----Glu mutant, only minor localized spectral changes were observed, confirming that the tertiary structure of the protein is preserved upon mutation. In contrast, for both the Arg-41----His and Tyr-13----Leu variants, significant and strikingly similar spectra changes were observed for many residues located far away from the mutated residues. This implies that similar structural alterations have taken place in both proteins, an idea further supported by hydrogen-exchange experiments where the exchange rates of hydrogen-bonded amide protons for both the Tyr-13----Leu and the Arg-41----His mutants were found to be about 4 times faster than in the wild-type protein.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909576     DOI: 10.1021/bi00100a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Structure-function studies of mEGF: probing the type I beta-turn between residues 25 and 26.

Authors:  C C Lester; B Wang; R Wu; H A Scheraga
Journal:  J Protein Chem       Date:  1995-11

2.  Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

Authors:  T Tsuboi; D C Kaslow; M M Gozar; M Tachibana; Y M Cao; M Torii
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

3.  Combined use of 13C chemical shift and 1H alpha-13C alpha heteronuclear NOE data in monitoring a protein NMR structure refinement.

Authors:  B Celda; C Biamonti; M J Arnau; R Tejero; G T Montelione
Journal:  J Biomol NMR       Date:  1995-02       Impact factor: 2.835

4.  Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity.

Authors:  Haeshin Lee; Tae Gwan Park
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

5.  N-terminal site-specific mono-PEGylation of epidermal growth factor.

Authors:  Haeshin Lee; Il Ho Jang; Sung Ho Ryu; Tae Gwan Park
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

6.  Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis.

Authors:  Richard A Stein; James V Staros
Journal:  BMC Evol Biol       Date:  2006-10-06       Impact factor: 3.260

7.  Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways.

Authors:  Dan Bao; Dan Lu; Ning Liu; Wei Dong; Ying-Dong Lu; Chuan Qin; Lian-Feng Zhang
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

8.  Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4.

Authors:  K Nagata; D Kohda; H Hatanaka; S Ichikawa; S Matsuda; T Yamamoto; A Suzuki; F Inagaki
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

9.  Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain.

Authors:  Hannes H Loeffler; Martyn D Winn
Journal:  Proteins       Date:  2013-08-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.